Spending power
TheGrid Corporate Spending Power index would rate purchasing capacity from registry, scale and activity signals.
Spending power
Key facts
Counted staff
26
self-reported 11–50 band
Founded
1989
37 years
Legal entities
None matched
Office countries
1
2 addresses
Funding rounds
None on record
Company type
Nonprofit
self-reported
Description
The Trans Tasman Radiation Oncology Group (TROG Cancer Research) conducts world-class research involving radiotherapy to improve outcomes and quality of life for people affected by cancer.
Our trial portfolio encompasses research into all tumour sites that can be treated with radiotherapy including skin, breast, prostate and bladder, lung, head & neck, and gynaecological cancers.
TROG is a network of over 1,200 health professionals conducting research across Australia and New Zealand. TROG membership is held by the majority of radiation oncologists in Australia and also consists of radiation therapists, clinical trial coordinators, data managers, medical physicists, nurses, statisticians, medical oncologists, surgeons and registrars.
TROG clinical trials are run at more than 200 international sites in countries including Australia, New Zealand, United Kingdom, Canada, The Netherlands, Norway, Belgium, France, Switzerland, Italy, Brazil, Singapore and India.
In 2013, TROG received the 'Innovation in Cancer Clinical Trials' award at the NSW Premiers Awards for Outstanding Cancer Research.
TROG is one of 14 National Cancer Cooperative Trials Groups. We are a not-for-profit organisation.
TROG's Central Operations Office is fully equipped to provide full trial coordination centre activities from the time of trial concept through to completion and publication in medical journals.
Specialties
All 6 specialties
- cancer research
- clinical trials
- radiation oncology
- radiotherapy research
- clinical trial coordination
- quality assurance
Related specialties
Locations
Country footprint
Show as table · Offices in 1 country
| Countries | 1 |
|---|---|
| Primary country | AU |
All codes: AU
Addresses
- AUCalvary Mater Newcastle; PO Box 88; Waratah, NSW 2289Primary
- AUCalvary Mater Newcastle; Waratah, NSW 2289
Grid intelligence Members
Signals & hiring
Hiring, headcount and registry-change signals, streamed to members.
Latest signal
Hiring activity
Headcount trend
Financials
Registry-filed capital and financial indicators, standardised by TheGrid.
Paid-up capital
Fiscal period
Registered charges
Revenue
Profit / loss
People & contacts
4 employee profiles on record · names withheld.
Names and titles are intentionally absent from this page. The source relation carries no consent record across the privacy regimes this directory spans, so it is never requested and never stored. Search engines see exactly what you see here.
Names are withheld until a consented source exists.
FAQ
How many people work at this brand?
26 counted staff profiles at January 2026, inside the self-reported 11–50 band.
Where does Trans Tasman Radiation Oncology Group (TROG Cancer Research) have offices?
Two addresses on record, Australia only. Primary: Calvary Mater Newcastle, PO Box 88, Waratah, NSW 2289.
Has Trans Tasman Radiation Oncology Group (TROG Cancer Research) raised funding?
None linked to this brand.
What does this brand list as its specialties?
Six tags on the brand's own list, among them clinical trials, cancer research and quality assurance.
Which companies are listed alongside this brand?
4 profiles list Trans Tasman Radiation Oncology Group (TROG Cancer Research) as a peer. It lists ten peers of its own. Head and Neck Cancer Australia and ANZUP Cancer Trials Group Limited list it back.